Health and Medicine | MedBlog | UT Southwestern Medical Center

Discovery; Transplant

Cystic fibrosis breakthrough: 3-drug combo pill may benefit 90% of patients

A new 3-drug combo drug for cystic fibrosis has been approved by the FDA. TRIKAFTA offers life-changing treatment potential for approximately 90% of patients with the disease. In this MedBlog, discover who is eligible and how the drug works. Learn more.

Raksha Jain, M.D.

March 6, 2020

Cancer; Discovery; Prevention

Precision medicine, immunotherapy drive largest single-year drop in cancer deaths

Cancer death rates have dropped nearly 30% since 1991, and more that 2% between 2016 and 2017 alone – the biggest one-year drop on record. The driver has been precision medicine, an approach that focuses on personalization and collaboration. Learn more now.

John Sweetenham, M.D.

January 15, 2020

Discovery; Heart

Improving treatment for abdominal aortic aneurysm – without open surgery

Abdominal aortic aneurysms take 15,000 lives in the U.S. each year. UT Southwestern is part of a clinical study to examine the effectiveness of a new device that may give more patients access to a less-invasive option to repair abdominal aortic aneurysms. Learn more

Melissa Kirkwood, M.D.

January 9, 2020

Discovery; Heart; Prevention

Obesity and high blood pressure: How a supplement might break the link

Obesity is one of the main causes of high blood pressure, although the connection has not been well understood. But Philip Shaul, M.D., and colleagues recently discovered that changes in our sugar molecules might be the missing link – and a supplement might help break the link. Learn more.

Philip Shaul, M.D.

December 26, 2019